ArticleBrain informatics2026
Perivascular fluid clearance links choroid plexus changes to cognitive performance in cerebral small vessel disease.
Article in Brain informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Choroid plexus (CP) dysfunction may impair cerebrospinal fluid (CSF) turnover and perivascular glymphatic clearance, but whether CP microstructural injury correlates to cerebral small vessel disease (CSVD)-related brain alteration and cognitive performance remains unclear. We investigated whether imaging markers of perivascular fluid transport mediate the associations between CP alterations and CSVD pathology. CP microstructure was assessed by mean apparent propagator (MAP) diffusion imaging and χ-separation susceptibility mapping in 139 CSVD patients and 52 healthy controls. Perivascular clearance measures included the diffusion tensor image-along perivascular space (DTI-ALPS) index, basal ganglia free-water fraction (FW-BG), and perivascular space volume fraction (PVSVF-BG). Compared with controls, CSVD patients showed CP microstructural abnormalities and altered perivascular clearance markers, which was identified by random-forest model as predictors of CSVD severity (OOB-AUC = 0.755, 95%CI: 0.641-0.836). Mediation analysis revealed that imaging markers of perivascular fluid clearance significantly mediated the associations between CP alterations and structural brain injury (average causal mediation effect , ACME=-110.118 to 80.121, FDR-p < 0.05). Notably, PVSVF-BG was the only glymphatic imaging metric mediating the links of both CP volume and susceptibility with cognitive performance (ACME=-142.474 to 67.351, FDR-p < 0.05). These findings indicate that CP microstructural injury are present in mild CSVD with the absence of CP volumetric enlargement, and are associated with CSVD markers and cognitive performance, which are mediated by disrupted perivascular fluid transport, highlighting the CP-glymphatic axis as a candidate pathway for further longitudinal and mechanistic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.